Outlook Therapeutics
- Biological Products, Except Diagnostic Substances
- Iselin, New Jersey
Compensation history
Top executives at Outlook Therapeutics received an average of $1M per person in annual compensation from 2015 to 2023.
By year
Executives
We found eight executives who work or worked at Outlook Therapeutics.
C Trenary
Outlook Therapeutics
Chief Executive Officer
Jeff Evanson
Outlook Therapeutics
Chief Commercial Officer
Terry Dagnon
Outlook Therapeutics
Former Chief Operations Officer
Lawrence Kenyon
Outlook Therapeutics
Chief Financial Officer
Pankaj Mohan
Outlook Therapeutics
Chief Executive Officer
Kenneth Bahrt
Outlook Therapeutics
Chief Medical Officer
Stephen McAndrew
Outlook Therapeutics
Former Senior Vice President, Business Strategy & Development
Kogan Bao
Outlook Therapeutics
Former Vice President, Analytical Sciences
News
Outlook Therapeutics CEO C Trenary's 2023 pay jumps 32% to $1.8M
February 8, 2024
Outlook Therapeutics Chief Operations Officer Terry Dagnon's 2022 pay jumps 378% to $1.4M
February 15, 2023
Outlook Therapeutics CEO C Trenary receives $7.5M in 2021
January 27, 2022
Outlook Therapeutics CEO Lawrence Kenyon's 2020 pay falls 36% to $1.2M
February 22, 2021
Outlook Therapeutics CEO Pankaj Mohan's 2018 pay rises 14% to $1.2M
August 1, 2019
About Outlook Therapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Biological Products, Except Diagnostic Substances
- 485 Route 1 South, Building F, Suite 320, Iselin, New Jersey 08830
- 6096193990
- September 30
- Former names
- Oncobiologics, Inc.